The McCoy lab studies mechanisms driving dryness and autoimmunity. We work to dissentangle the immunobiology of mesenchymal stromal cells as a targetable cell for therapeutic intervention. We model disease in 2d co-culture systems, organoids, microfluidics systems, and mice. Our goal is to identify novel MSC targets to treat autoimmunity and dryness. Another focus of the lab is to identify and understand novel autoantibodies in Sjogren’s disease. Our work is highly translational and we deployed the first study of marrow-derived MSCs to treat SjD and GvHD.

Our mission is to use collaboration & the unique strengths of our team members, we gain pathogenic insights into glandular immunobiology, improving quality of life & developing cures for patients with dryness & autoimmunity

News

Dr. Sara McCoy selected as the recipient of Case Western Reserve University School of Medicine's 2025 Early Career Leadership Award

Dr. Valeria Manfre awarded prestigous pilot grant from the Sjogren's Foundation

McCoy Lab publication cited as one of 2024's most important publications in rheumatology

FDA approves IND to treat medical xerostomia with MSCs